NCT01590316View on ClinicalTrials.gov

SafeBoosC - a Phase II Trial

NACompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

March 31, 2018

Conditions
Brain InjuriesInfant, Premature
Interventions
DEVICE

Cerebral NIRS oximetry

Cerebral NIRS oximetry during the first 72 hours of life.

Trial Locations (1)

2100

Department of Neonatology, Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Gorm Greisen

OTHER

NCT01590316 - SafeBoosC - a Phase II Trial | Biotech Hunter | Biotech Hunter